共 9 条
[1]
Development of quinoloneimipenem cross resistence in Pseudomonas aeruginosa during exposure to ciprofloxacin. Radberg G,Nillsson LE,Svensson S. Antimicrobial Agents and Chemotherapy . 1990
[2]
Alterations in outer membrane proteins of Pseudomonas aeruginosa associated with selective resistance to quinolones. Daikos GL,Lolans VT,Jackson GG. Antimicrobial Agents and Chemotherapy . 1998
[3]
Pseudomonas aeruginosa: a survey of resistance in 136 hospitals in Spain. Bouza E,Garrote-Garrote F,Cercenado E,et al. Antimicrobial Agents and Chemotherapy . 1999
[4]
Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections. Quinn JP,Dudek EJ,Di Vincezo CA,et al. The Journal of Infectious Diseases . 1986
[5]
Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa. Masuda N,Ohya S. Antimicrobial Agents and Chemotherapy . 1992
[6]
Fluorometric assay for fleroxacin uptake by bacterial cells. Chapman JS,Georgopapadakou NH. Antimicrobial Agents and Chemotherapy . 1989
[7]
Contribution of outer membrance efflux protein oprM to antibiotic resistance in Pseudomonas aeruginosa independent of MexAB. Zhao QX,Li XZ,Srikumar R,et al. Antimicrobial Agents and Chemotherapy . 1998
[8]
Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa:mexR encodes a regulator of operon expression. Poole K,Tetro T,Zhao Q,et al. Antimicrobial Agents and Chemotherapy . 1996
[9]
Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PA01 and quinolone-resistant clinical isolates. Kureishi A,Diver JM,Beckthold B,et al. Antimicrobial Agents and Chemotherapy . 1994